Article thumbnail
Location of Repository

Amniotic Fluid Stem Cells: Future Perspectives

By Margit Rosner, Katharina Schipany, Bharanidharan Shanmugasundaram, Gert Lubec and Markus Hengstschläger

Abstract

The existence of stem cells in human amniotic fluid was reported for the first time almost ten years ago. Since this discovery, the knowledge about these cells has increased dramatically. Today, amniotic fluid stem (AFS) cells are widely accepted as a new powerful tool for basic research as well as for the establishment of new stem-cell-based therapy concepts. It is possible to generate monoclonal genomically stable AFS cell lines harboring high proliferative potential without raising ethical issues. Many different groups have demonstrated that AFS cells can be differentiated into all three germ layer lineages, what is of relevance for both, the scientific and therapeutical usage of these cells. Of special importance for the latter is the fact that AFS cells are less tumorigenic than other pluripotent stem cell types. In this paper, we have summarized the current knowledge about this relatively young scientific field. Furthermore, we discuss the relevant future perspectives of this promising area of stem cell research focusing on the next important questions, which need to be answered

Topics: Review Article
Publisher: Hindawi Publishing Corporation
OAI identifier: oai:pubmedcentral.nih.gov:3375114
Provided by: PubMed Central

Suggested articles

Citations

  1. (2003). A .R .P r u s a ,E .M a r t o n ,M .R o s n e r ,G .B e r n a s c h e k ,a n dM . Hengstschl¨ ager, “Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research?” Human Reproduction,
  2. (2002). A .R .P r u s aa n dM .H e n g s t s c h l ¨ ager, “Amniotic fluid cells and humanstemcellresearch—anewconnection,”MedicalScience Monitor,
  3. (2010). A.Valli,M.Rosner,C.Fuchsetal.,“Embryoidbodyformation of human amniotic fluid stem cells depends on mTOR,”
  4. (1983). Amniotic fluid cell types and culture,”
  5. (2007). Amniotic fluid derived stem cells ameliorate focal cerebral ischaemiareperfusion injury induced behavioural deficits in mice,”
  6. (2012). Amniotic fluid stem cell-based modelstostudytheeffectsofgenemutationsandtoxicantsonmale germ cell formation,”
  7. (2005). andM.H engstschl¨ ager,“ActivationofectopicOct-4andRex-1 promoters in human amniotic fluid cells,”
  8. (2003). Bernaschek,andM.Hengstschl¨ ager, “Stemcellmarkerexpression in human trisomy 21 amniotic fluid cells and trophoblasts,”
  9. (2007). Chondrogenic differentiation of amniotic fluidderived stem cells,”
  10. (2009). Creation of a registry for human embryonic stem cells carrying an inherited defect: joint collaboration between ESHREandhESCreg,”HumanReproduction,v ol.24,no .7,pp .
  11. (2011). Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture,”
  12. (2010). Epigenetic memory in induced pluripotent stem cells,”
  13. (2010). Human amniotic fluid as a potential new source of organ specific precursor cells for future regenerative medicine applications,”
  14. (2011). Human amniotic fluid stem cells as a model for functional studies of genes involved in human genetic diseases or oncogenesis,”
  15. (2007). Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells,”
  16. Induced pluripotent stem cells: a new revolution for clinical neurology?”
  17. (2009). Induction of mesenchymal/epithelial marker expression in human amniotic fluid stem cells,”
  18. (2011). Investigating monogenic and complex diseases with pluripotent stem cells,”
  19. (2007). Isolation of amniotic stem cell lines with potential for therapy,”
  20. (2006). Molecular and phenotypiccharacterizationofhumanamnioticfluidcellsand their differentiation potential,”
  21. Morphological and biochemical heterogeneity of amniotic fluid cells in culture,”
  22. (2004). Neurogenic cells in human amniotic fluid,”
  23. (2011). Neurogenic differentiation of amniotic fluid stem cells,” Amino Acids,
  24. (2003). P .S.In’tAnker ,S.A.Scherjon,C.Kleijburg-vanderK euretal., “Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation [1],”
  25. (2008). Primio, “Potential role of culture mediums for successful isolation and neuronal differentiation of amniotic fluid stem cells,”
  26. (2010). Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis,”
  27. (2007). Renal differentiation of amniotic fluid stem cells,”
  28. Renal differentiation of amniotic fluid stem cells: perspectives for clinical application and for studies on specific human genetic diseases,” European Journal of Clinical Investigation.
  29. (2010). Stem cells derived from human amniotic fluid contribute to acute kidney injury recovery,”
  30. (2004). T s a i ,J .L .L e e ,Y .J .C h a n g ,a n dS .M .H w a n g ,“ I s o l a t i o n of human multipotent mesenchymal stem cells from secondtrimester amniotic fluid using a novel two-stage culture protocol,”
  31. (2001). The amniotic fluid as a source of cells for fetal tissue engineering,”
  32. (2012). Tuberin and PRAS40 are anti-apoptotic gatekeepers during early human amniotic fluid stem cell differentiation,”
  33. (2010). Unbekandt et al., “Contribution of human amniotic fluid stem cells to renal tissue formation depends on mTOR,”

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.